Finance

Lists
Portfolios
Track your investments in one place, get AI insights, and more
Top movers in your lists
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXE
Energy
SIXE
Energy
SIXE
-2.11%
1,205.14
-26.00
-2.11%
β€”1,231.141,233.921,237.061,203.47β€”β€”
SIXV
Health care
SIXV
Health care
SIXV
+1.34%
1,658.73
+21.88
+1.34%
β€”1,636.851,635.521,670.051,635.52β€”β€”
SIXB
Materials
SIXB
Materials
SIXB
+1.20%
1,118.45
+13.30
+1.20%
β€”1,105.151,112.561,125.111,112.56β€”β€”
SIXC
Communications
SIXC
Communications
SIXC
-1.05%
579.08
-6.14
-1.05%
β€”585.22585.22589.50574.23β€”β€”
SIXU
Utilities
SIXU
Utilities
SIXU
-1.01%
883.81
-8.98
-1.01%
β€”892.79892.85892.86876.43β€”β€”
US market summary
The Dow Jones Industrial Average rose 0.5% to achieve another record close, marking its fifth consecutive positive session. Conversely, the Nasdaq Composite dropped 0.8% and the S&P 500 fell 0.2% as major technology companies pulled back from recent peaks, snapping earlier winning streaks.
Dive deeper with AI
SpaceX shares plunge on massive artificial intelligence infrastructure spending
In its debut earnings report as a public entity, SpaceX saw its shares tumble up to 14% after revealing aggressive plans for capital expenditures directed at AI infrastructure. Despite beating quarterly revenue expectations, the high cost projections unnerved investors and dampened broad enthusiasm for the technology trade.
Dive deeper with AI
Nvidia rallies following exclusive supply deal news from Elon Musk
Shares of Nvidia climbed more than 3% during mid-week trading, defying the broader downturn experienced by other major semiconductor manufacturers. The boost followed public confirmations that SpaceX will exclusively source Nvidia chips to fuel its rapidly expanding AI computing initiatives.
Dive deeper with AI
Corporate earnings upgrades spark strong gains in healthcare sector
The S&P 500 healthcare index rallied 1.3%, driven by exceptionally strong updates from prominent drug developers. Eli Lilly advanced nearly 5% after upwardly revising its full-year revenue expectations, while rival pharmaceutical firm Amgen surged 4.6% on the heels of robust quarterly sales growth.
Dive deeper with AI
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps